Xincere Medical Technology Co., Ltd., is the leading Decentralized Clinical Trial (DCT) platform solution supplier in China, focuses on the development of a patient-centric intelligent platform for remote clinical trials. Powered by the application of digital technology in clinical trials, Xincere strives to improve the accessibility of clinical trials, to alleviate the burden of patients, to advance the quality and efficiency of clinical studies, and to reduce the cost of drug R&D. Incubated from Jsure Health after a four-year endeavor, Xincere has developed a business line featuring includes: ePData – integrated electric Clinical Outcome Assessment (eCOA) solution, ePVisit – remote visit solution, ePScale – introduction and copyright management service for domestic and international scales. With the integrated eCOA solution compatible with local application in China, Xincere now proudly boasts dozens of successful cases of Phase II/III clinical trial projects, and the unprecedented application of remote visit solution in China. Devoted to digital technology development as support for novel drug R&D advancement in China, we hope to help the patients and benefit the society.